Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bridging the Gap Between Fluid Biomarkers for Alzheimer’s Disease, Model Systems, and Patients
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-02
DOI
10.3389/fnagi.2020.00272
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
- (2020) Nicholas J. Ashton et al. Nature Reviews Neurology
- Tau PET imaging in neurodegenerative tauopathies—still a challenge
- (2019) Antoine Leuzy et al. MOLECULAR PSYCHIATRY
- Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes
- (2019) Matthew P. Pase et al. JAMA Neurology
- The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans
- (2019) Jerrah K. Holth et al. SCIENCE
- Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease
- (2019) S. Swarbrick et al. MOLECULAR NEUROBIOLOGY
- Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
- (2019) Niklas Mattsson et al. JAMA Neurology
- Cerebrospinal fluid from Alzheimer’s disease patients promotes tau aggregation in transgenic mice
- (2019) Zhiva Skachokova et al. Acta Neuropathologica Communications
- LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease
- (2019) Bradlee L. Heckmann et al. CELL
- Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers
- (2019) Jinny Claire Lee et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Neuroimaging Biomarkers for Alzheimer’s Disease
- (2019) Freddie Márquez et al. Molecular Neurodegeneration
- NAD+ in Brain Aging and Neurodegenerative Disorders
- (2019) Sofie Lautrup et al. Cell Metabolism
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease
- (2018) Courtney L. Sutphen et al. Alzheimers & Dementia
- Effect of sleep on overnight cerebrospinal fluid amyloid β kinetics
- (2018) Brendan P. Lucey et al. ANNALS OF NEUROLOGY
- Micro RNA as a potential blood-based epigenetic biomarker for Alzheimer's disease
- (2018) Peter D. Fransquet et al. CLINICAL BIOCHEMISTRY
- Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
- (2018) Maria Bjerke et al. JOURNAL OF ALZHEIMERS DISEASE
- Biomarkers for Alzheimer Disease: Classical and Novel Candidates’ Review
- (2018) Nadia El Kadmiri et al. NEUROSCIENCE
- White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
- (2018) Charlotte E. Teunissen et al. Alzheimers Research & Therapy
- Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
- (2018) Manuel Menendez-Gonzalez et al. Frontiers in Aging Neuroscience
- Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
- (2018) Md. Sahab Uddin et al. Frontiers in Aging Neuroscience
- Zinc Binding to S100B Affords Regulation of Trace Metal Homeostasis and Excitotoxicity in the Brain
- (2018) Simone Hagmeyer et al. Frontiers in Molecular Neuroscience
- The neuronal S100B protein is a calcium-tuned suppressor of amyloid-β aggregation
- (2018) Joana S. Cristóvão et al. Science Advances
- Plasma amyloid as pre-screener for the earliest Alzheimer's pathological changes
- (2018) Inge M.W. Verberk et al. ANNALS OF NEUROLOGY
- Tau Transgenic Mice as Models for Cerebrospinal Fluid Tau Biomarkers
- (2018) Donna M. Barten et al. JOURNAL OF ALZHEIMERS DISEASE
- Risk of Alzheimer's Disease Biological Misdiagnosis Linked to Cerebrospinal Collection Tubes
- (2018) Armand Perret-Liaudet et al. JOURNAL OF ALZHEIMERS DISEASE
- Ventricular and Lumbar Cerebrospinal Fluid Concentrations of Alzheimer's Disease Biomarkers in Patients with Normal Pressure Hydrocephalus and Posttraumatic Hydrocephalus
- (2018) Sebastian Brandner et al. JOURNAL OF ALZHEIMERS DISEASE
- CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
- (2018) Shorena Janelidze et al. NEUROLOGY
- Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
- (2018) Piotr Lewczuk et al. Alzheimers Research & Therapy
- Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease
- (2018) Juan R. Perea et al. Frontiers in Neuroscience
- Current state of Alzheimer’s fluid biomarkers
- (2018) José Luis Molinuevo et al. ACTA NEUROPATHOLOGICA
- CNS-Wide over Expression of Fractalkine Improves Cognitive Functioning in a Tauopathy Model
- (2018) Dylan J. Finneran et al. Journal of Neuroimmune Pharmacology
- Biomarkers for tau pathology
- (2018) Michael Schöll et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- The Cerebrospinal Fluid Aβ1–42/Aβ1–40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer’s Disease in a Clinical Setting
- (2017) Ellis Niemantsverdriet et al. JOURNAL OF ALZHEIMERS DISEASE
- BACE1 Dynamics Upon Inhibition with a BACE Inhibitor and Correlation to Downstream Alzheimer’s Disease Markers in Elderly Healthy Participants
- (2017) Maarten Timmers et al. JOURNAL OF ALZHEIMERS DISEASE
- Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment
- (2017) Francis T. Hane et al. JOURNAL OF ALZHEIMERS DISEASE
- YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
- (2017) Marta Querol-Vilaseca et al. Journal of Neuroinflammation
- Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain
- (2017) Sneha Narasimhan et al. JOURNAL OF NEUROSCIENCE
- Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition
- (2017) Chia-Chen Liu et al. JOURNAL OF NEUROSCIENCE
- Absence of CX3CR1 impairs the internalization of Tau by microglia
- (2017) Marta Bolós et al. Molecular Neurodegeneration
- TREM2 in Neurodegenerative Diseases
- (2017) Taylor R. Jay et al. Molecular Neurodegeneration
- Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation
- (2017) Zhuohao He et al. NATURE MEDICINE
- [18F]FDG PET signal is driven by astroglial glutamate transport
- (2017) Eduardo R Zimmer et al. NATURE NEUROSCIENCE
- Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease
- (2017) Simone Lista et al. NEUROCHEMISTRY INTERNATIONAL
- Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
- (2017) Anne Maass et al. NEUROIMAGE
- Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias
- (2017) Petra Steinacker et al. NEUROLOGY
- CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration
- (2017) Daniel Alcolea et al. NEUROLOGY
- Disease-Induced Alterations in Brain Drug Transporters in Animal Models of Alzheimer’s Disease
- (2017) Kati-Sisko Vellonen et al. PHARMACEUTICAL RESEARCH
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
- (2017) Lutz Frölich et al. Alzheimers Research & Therapy
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Potential Roles of Exosomal MicroRNAs as Diagnostic Biomarkers and Therapeutic Application in Alzheimer’s Disease
- (2017) Jian-jiao Chen et al. NEURAL PLASTICITY
- Characterization of tau prion seeding activity and strains from formaldehyde-fixed tissue
- (2017) Sarah K. Kaufman et al. Acta Neuropathologica Communications
- Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions
- (2017) Marta Sidoryk-Wegrzynowicz et al. Acta Neuropathologica Communications
- What is the evidence that tau pathology spreads through prion-like propagation?
- (2017) Amrit Mudher et al. Acta Neuropathologica Communications
- CHF5074, a Novel γ-Secretase Modulator, Restores Hippocampal Neurogenesis Potential and Reverses Contextual Memory Deficit in a Transgenic Mouse Model of Alzheimer's Disease
- (2017) Bruno P. Imbimbo et al. JOURNAL OF ALZHEIMERS DISEASE
- Comparison of Conventional ELISA with Electrochemiluminescence Technology for Detection of Amyloid-β in Plasma
- (2017) Esther S. Oh et al. JOURNAL OF ALZHEIMERS DISEASE
- Alzheimer's Disease and the Amyloid-β Peptide
- (2017) M. Paul Murphy et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuroinflammation in Alzheimer's disease: Current evidence and future directions
- (2016) Valeria Calsolaro et al. Alzheimers & Dementia
- Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients
- (2016) Shuko Takeda et al. ANNALS OF NEUROLOGY
- In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
- (2016) Hanna Cho et al. ANNALS OF NEUROLOGY
- TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia
- (2016) Bryan D. James et al. BRAIN
- Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
- (2016) Antoine Leuzy et al. BRAIN
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Early and protective microglial activation in Alzheimer’s disease: a prospective study using18F-DPA-714 PET imaging
- (2016) Lorraine Hamelin et al. BRAIN
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
- (2016) Lidia Bakota et al. DRUGS
- sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers
- (2016) Marc Suárez‐Calvet et al. EMBO Molecular Medicine
- Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer’s Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks
- (2016) Wasco Wruck et al. JOURNAL OF ALZHEIMERS DISEASE
- Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer’s Disease: Analytical and Diagnostic Characterization
- (2016) Piotr Lewczuk et al. JOURNAL OF ALZHEIMERS DISEASE
- Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease
- (2016) Vo Van Giau et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Aggregation of the Inflammatory S100A8 Precedes Aβ Plaque Formation in Transgenic APP Mice: Positive Feedback for S100A8 and Aβ Productions
- (2016) Maria Lodeiro et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Refinement of a model of repeated cerebrospinal fluid collection in conscious rats
- (2016) Eva Maria Amen et al. LABORATORY ANIMALS
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
- (2016) Alexander G. Thompson et al. Nature Reviews Neurology
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia
- (2016) Jonathan D. Rohrer et al. NEUROLOGY
- Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
- (2016) Mehtap Bacioglu et al. NEURON
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS -amyloid in animal models and in Alzheimers disease patients
- (2016) M. E. Kennedy et al. Science Translational Medicine
- The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
- (2016) Annika Öhrfelt et al. Alzheimers Research & Therapy
- Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression
- (2016) Henrik Zetterberg et al. JAMA Neurology
- Tau: The Center of a Signaling Nexus in Alzheimer's Disease
- (2016) Shahzad S. Khan et al. Frontiers in Neuroscience
- Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
- (2016) Julio C. Rojas et al. Annals of Clinical and Translational Neurology
- Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study
- (2016) Magnus Gisslén et al. EBioMedicine
- Plasma β-amyloid in Alzheimer’s disease and vascular disease
- (2016) Shorena Janelidze et al. Scientific Reports
- Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
- (2016) Petra Steinacker et al. Scientific Reports
- The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015
- (2015) William J. Jagust et al. Alzheimers & Dementia
- In vivo braak staging using 18F-AV1451 Tau PET imaging
- (2015) Michael Schöll et al. Alzheimers & Dementia
- C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
- (2015) Ann De Vos et al. Alzheimers & Dementia
- Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease
- (2015) Kaj Blennow et al. Alzheimers & Dementia
- Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis
- (2015) Patrick Weydt et al. ANNALS OF NEUROLOGY
- Identification of amyloid beta mid-domain fragments in human cerebrospinal fluid
- (2015) Magnus Rogeberg et al. BIOCHIMIE
- Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain
- (2015) Nicole Maphis et al. BRAIN
- A balanced view of the cerebrospinal fluid composition and functions: Focus on adult humans
- (2015) Reynold Spector et al. EXPERIMENTAL NEUROLOGY
- Immunohistochemical analysis of transporters related to clearance of amyloid-β peptides through blood–cerebrospinal fluid barrier in human brain
- (2015) Koichi Matsumoto et al. HISTOCHEMISTRY AND CELL BIOLOGY
- A novel method to study cerebrospinal fluid dynamics in rats
- (2015) Jason K. Karimy et al. JOURNAL OF NEUROSCIENCE METHODS
- The Role of TDP-43 in Alzheimer’s Disease
- (2015) Xiao-Long Chang et al. MOLECULAR NEUROBIOLOGY
- Analysis of in vivo turnover of tau in a mouse model of tauopathy
- (2015) Kaoru Yamada et al. Molecular Neurodegeneration
- Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
- (2015) Irina Milisav et al. MOLECULES
- Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
- (2015) Erik S Musiek et al. NATURE NEUROSCIENCE
- Depletion of microglia and inhibition of exosome synthesis halt tau propagation
- (2015) Hirohide Asai et al. NATURE NEUROSCIENCE
- Compromised autophagy and neurodegenerative diseases
- (2015) Fiona M. Menzies et al. NATURE REVIEWS NEUROSCIENCE
- Post-mortem analysis of neuroinflammatory changes in human Alzheimer’s disease
- (2015) Diego Gomez-Nicola et al. Alzheimers Research & Therapy
- Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease
- (2015) Jon B. Toledo et al. JAMA Neurology
- Targeting Prodromal Alzheimer Disease With Avagacestat
- (2015) Vladimir Coric et al. JAMA Neurology
- Chasing the Effects of Pre-Analytical Confounders – A Multicenter Study on CSF-AD Biomarkers
- (2015) Maria João Leitão et al. Frontiers in Neurology
- Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
- (2015) Aaron Ritter et al. Frontiers in Neurology
- A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity
- (2014) Zeshan Ahmed et al. ACTA NEUROPATHOLOGICA
- Tau aggregation and its interplay with amyloid-β
- (2014) Rebecca M. Nisbet et al. ACTA NEUROPATHOLOGICA
- The Ca2+ sensor S100A1 modulates neuroinflammation, histopathology and Akt activity in the PSAPP Alzheimer's disease mouse model
- (2014) Lauriaselle Afanador et al. CELL CALCIUM
- Mass Spectrometry-Based Candidate Reference Measurement Procedure for Quantification of Amyloid- in Cerebrospinal Fluid
- (2014) A. Leinenbach et al. CLINICAL CHEMISTRY
- Revisiting the peripheral sink hypothesis: inhibiting BACE1 activity in the periphery does not alter β-amyloid levels in the CNS
- (2014) Biljana Georgievska et al. JOURNAL OF NEUROCHEMISTRY
- Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome
- (2014) J. Kuhle et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A Sensitive A Oligomer Assay Discriminates Alzheimer's and Aged Control Cerebrospinal Fluid
- (2014) M. J. Savage et al. JOURNAL OF NEUROSCIENCE
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
- (2014) Ann Brinkmalm et al. Molecular Neurodegeneration
- Amyloid precursor-like protein 2 C-terminal fragments upregulate S100A9 gene and protein expression in BV2 cells
- (2014) Yanji Xu et al. Neural Regeneration Research
- Alzheimer’s and ABC transporters — new opportunities for diagnostics and treatment
- (2014) Jens Pahnke et al. NEUROBIOLOGY OF DISEASE
- Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus
- (2014) Okko T. Pyykkö et al. PLoS One
- Novel plasma biomarker surrogating cerebral amyloid deposition
- (2014) Naoki KANEKO et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
- (2014) G. Kleinberger et al. Science Translational Medicine
- Resting State Functional Connectivity in Preclinical Alzheimer’s Disease
- (2013) Yvette I. Sheline et al. BIOLOGICAL PSYCHIATRY
- Identification of an important potential confound in CSF AD studies: aliquot volume
- (2013) Jamie Toombs et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Characterization of Intermediate Steps in Amyloid Beta (Aβ) Production under Near-native Conditions
- (2013) Fredrik Olsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Amyloid-β peptide-induced extracellular S100A9 depletion is associated with decrease of antimicrobial peptide activity in human THP-1 monocytes
- (2013) Eun Ok Lee et al. Journal of Neuroinflammation
- Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy
- (2013) Kevin R. Nash et al. NEUROBIOLOGY OF AGING
- Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later
- (2013) C. M. Roe et al. NEUROLOGY
- Brain -amyloid load approaches a plateau
- (2013) C. R. Jack et al. NEUROLOGY
- Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer’s Disease
- (2013) Andrea Armstrong et al. NEUROMOLECULAR MEDICINE
- Alzheimer disease
- (2013) Justin M. Nussbaum et al. Prion
- Brain homogenates from human tauopathies induce tau inclusions in mouse brain
- (2013) Florence Clavaguera et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic responses in mouse models poorly mimic human inflammatory diseases
- (2013) Junhee Seok et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Perspectives in Molecular Imaging Using Staging Biomarkers and Immunotherapies in Alzheimer’s Disease
- (2013) Benoît Leclerc et al. TheScientificWorldJOURNAL
- Evidence for impaired amyloid β clearance in Alzheimer's disease
- (2013) Kristin R Wildsmith et al. Alzheimers Research & Therapy
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
- (2013) L. Mucke et al. Cold Spring Harbor Perspectives in Medicine
- Brain Imaging in Alzheimer Disease
- (2013) K. A. Johnson et al. Cold Spring Harbor Perspectives in Medicine
- Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage
- (2013) G. K. Sheridan et al. Open Biology
- A blood based 12-miRNA signature of Alzheimer disease patients
- (2013) Petra Leidinger et al. GENOME BIOLOGY
- Development of biomarkers to chart all Alzheimer’s disease stages: The royal road to cutting the therapeutic Gordian Knot
- (2012) Harald Hampel et al. Alzheimers & Dementia
- Amyloid deposition, hypometabolism, and longitudinal cognitive decline
- (2012) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Ubiquitous Amyloids
- (2012) Wojciech Pulawski et al. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Amyloid-β–Associated Clinical Decline Occurs Only in the Presence of Elevated P-tau
- (2012) Rahul S. Desikan et al. ARCHIVES OF NEUROLOGY
- Cerebrospinal Fluid Collection Tubes: A Critical Issue for Alzheimer Disease Diagnosis
- (2012) A. Perret-Liaudet et al. CLINICAL CHEMISTRY
- A Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Avagacestat (BMS-708163) in Healthy Young and Elderly Subjects
- (2012) Randy Dockens et al. CLINICAL PHARMACOKINETICS
- Cerebrospinal Fluid Biomarkers and Proximity to Diagnosis in Preclinical Familial Alzheimer's Disease
- (2012) John M. Ringman et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease
- (2012) Fredrik Jeppsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain
- (2012) Ylva Gravenfors et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mrp14 Deficiency Ameliorates Amyloid Burden by Increasing Microglial Phagocytosis and Modulation of Amyloid Precursor Protein Processing
- (2012) M. P. Kummer et al. JOURNAL OF NEUROSCIENCE
- Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease
- (2012) Guoxin Wu et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Molecular machines governing exocytosis of synaptic vesicles
- (2012) Reinhard Jahn et al. NATURE
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Immunotherapy for Alzheimer disease—the challenge of adverse effects
- (2012) Yu-Hui Liu et al. Nature Reviews Neurology
- Two cortical systems for memory-guided behaviour
- (2012) Charan Ranganath et al. NATURE REVIEWS NEUROSCIENCE
- The Role of S100a9 in the Pathogenesis of Alzheimers Disease: The Therapeutic Effects of S100a9 Knockdown or Knockout
- (2012) Keun-A Chang et al. Neurodegenerative Diseases
- Prediction of Alzheimer's disease in subjects with mild cognitive impairment from the ADNI cohort using patterns of cortical thinning
- (2012) Simon F. Eskildsen et al. NEUROIMAGE
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allen Brain Atlas: an integrated spatio-temporal portal for exploring the central nervous system
- (2012) Susan M. Sunkin et al. NUCLEIC ACIDS RESEARCH
- CSF-Biomarkers in Olympic Boxing: Diagnosis and Effects of Repetitive Head Trauma
- (2012) Sanna Neselius et al. PLoS One
- Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials
- (2012) Dominic Holland et al. PLoS One
- Pathological Alteration in the Choroid Plexus of Alzheimer’s Disease: Implication for New Therapy Approaches
- (2012) Agnieszka Krzyzanowska et al. Frontiers in Pharmacology
- The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers
- (2011) Niklas Mattsson et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Amyloid-β associated volume loss occurs only in the presence of phospho-tau
- (2011) Rahul S. Desikan et al. ANNALS OF NEUROLOGY
- Unbiased comparison of sample size estimates from longitudinal structural measures in ADNI
- (2011) Dominic Holland et al. HUMAN BRAIN MAPPING
- Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
- (2011) Sudad Saman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aging reduces total neuron number in the dorsal component of the rodent prefrontal cortex
- (2011) Alexis M. Stranahan et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation
- (2011) S. Hong et al. JOURNAL OF NEUROSCIENCE
- In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice
- (2011) K. Yamada et al. JOURNAL OF NEUROSCIENCE
- The potential role of microRNA-146 in Alzheimer’s disease: Biomarker or therapeutic target?
- (2011) Li-Ling Wang et al. MEDICAL HYPOTHESES
- CSF tau markers are correlated with hippocampal volume in Alzheimer's disease
- (2011) Leonardo C. de Souza et al. NEUROBIOLOGY OF AGING
- Autophagy failure in Alzheimer's disease—locating the primary defect
- (2011) Ralph A. Nixon et al. NEUROBIOLOGY OF DISEASE
- Novel microdialysis method to assess neuropeptides and large molecules in free-moving mouse
- (2011) S. Takeda et al. NEUROSCIENCE
- Age-related memory deficits linked to circuit-specific disruptions in the hippocampus
- (2011) M. A. Yassa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture
- (2011) C J Garwood et al. Cell Death & Disease
- Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease
- (2011) Guriqbal S Basi et al. Alzheimers Research & Therapy
- The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
- (2010) Laurel A. Beckett et al. Alzheimers & Dementia
- The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
- (2010) Michael W. Weiner et al. Alzheimers & Dementia
- CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models
- (2010) Sungho Lee et al. AMERICAN JOURNAL OF PATHOLOGY
- Cerebrospinal Fluid Flow Dynamics in the Central Nervous System
- (2010) Brian Sweetman et al. ANNALS OF BIOMEDICAL ENGINEERING
- Correlation of Longitudinal Cerebrospinal Fluid Biomarkers With Cognitive Decline in Healthy Older Adults
- (2010) Erik Stomrud et al. ARCHIVES OF NEUROLOGY
- What Can Be Inferred from the Interruption of the Semagacestat Trial for Treatment of Alzheimer's Disease?
- (2010) Jeffrey Cummings BIOLOGICAL PSYCHIATRY
- A Meta-Analysis of Cytokines in Alzheimer's Disease
- (2010) Walter Swardfager et al. BIOLOGICAL PSYCHIATRY
- YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
- (2010) Rebecca Craig-Schapiro et al. BIOLOGICAL PSYCHIATRY
- Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
- (2010) Annika Thorsell et al. BRAIN RESEARCH
- Overview of macroautophagy regulation in mammalian cells
- (2010) Maryam Mehrpour et al. CELL RESEARCH
- Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau
- (2010) Antonella Caccamo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation
- (2010) Emily Roltsch et al. Journal of Neuroinflammation
- Acute -Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid- Production to Alternative APP Fragments without Amyloid- Rebound
- (2010) J. J. Cook et al. JOURNAL OF NEUROSCIENCE
- A causative link between the structure of aberrant protein oligomers and their toxicity
- (2010) Silvia Campioni et al. Nature Chemical Biology
- Traumatic brain injury and amyloid-β pathology: a link to Alzheimer's disease?
- (2010) Victoria E. Johnson et al. NATURE REVIEWS NEUROSCIENCE
- Rostrocaudal Dynamics of CSF Biomarkers
- (2010) Andrew Tarnaris et al. NEUROCHEMICAL RESEARCH
- S100a9 Knockdown Decreases the Memory Impairment and the Neuropathology in Tg2576 Mice, AD Animal Model
- (2010) Tae-Young Ha et al. PLoS One
- Selective Disruption of the Cerebral Neocortex in Alzheimer's Disease
- (2010) Rahul S. Desikan et al. PLoS One
- Amyloid β-Protein Aggregation Produces Highly Reproducible Kinetic Data and Occurs by a Two-Phase Process
- (2009) Erik Hellstrand et al. ACS Chemical Neuroscience
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
- (2009) Tero Tapiola et al. ARCHIVES OF NEUROLOGY
- Diffusion tensor imaging in mild cognitive impairment and Alzheimerʼs disease: a review
- (2009) Terence C Chua et al. CURRENT OPINION IN NEUROLOGY
- Total and phosphorylated tau protein as biological markers of Alzheimer’s disease
- (2009) Harald Hampel et al. EXPERIMENTAL GERONTOLOGY
- Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease
- (2009) Takashi Mori et al. GLIA
- Microglial VEGF Receptor Response Is an Integral Chemotactic Component in Alzheimer's Disease Pathology
- (2009) J. K. Ryu et al. JOURNAL OF NEUROSCIENCE
- Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice
- (2009) P. Yan et al. JOURNAL OF NEUROSCIENCE
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Review: Autophagy in neurodegeneration: firefighter and/or incendiarist?
- (2009) A. Rami NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10
- (2009) Weiping Qin et al. PLoS One
- Amyloid- and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice
- (2009) V. Rhein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Brain's Default Network
- (2008) Randy L. Buckner et al. Annals of the New York Academy of Sciences
- The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals
- (2008) Bradford C. Dickerson et al. CEREBRAL CORTEX
- Overexpression of Neprilysin Reduces Alzheimer Amyloid-β42 (Aβ42)-induced Neuron Loss and Intraneuronal Aβ42 Deposits but Causes a Reduction in cAMP-responsive Element-binding Protein-mediated Transcription, Age-dependent Axon Pathology, and Premature Death inDrosophila
- (2008) Kanae Iijima-Ando et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- AZD2184: a radioligand for sensitive detection of β-amyloid deposits
- (2008) Allan E. Johnson et al. JOURNAL OF NEUROCHEMISTRY
- Microglial Dysfunction and Defective -Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
- (2008) S. E. Hickman et al. JOURNAL OF NEUROSCIENCE
- The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of -Site Amyloid Precursor Protein-Cleaving Enzyme 1
- (2008) W.-X. Wang et al. JOURNAL OF NEUROSCIENCE
- Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
- (2008) L. Mosconi et al. JOURNAL OF NUCLEAR MEDICINE
- First Demonstration of Cerebrospinal Fluid and Plasma A Lowering with Oral Administration of a -Site Amyloid Precursor Protein-Cleaving Enzyme 1 Inhibitor in Nonhuman Primates
- (2008) S. Sankaranarayanan et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- CSF biomarkers in frontotemporal lobar degeneration with known pathology
- (2008) H. Bian et al. NEUROLOGY
- A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse
- (2008) Li Liu et al. Jove-Journal of Visualized Experiments
- Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
- (2007) Christin Andersson et al. NEUROBIOLOGY OF AGING
- Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
- (2007) Sebastiaan Engelborghs et al. NEUROBIOLOGY OF AGING
- Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
- (2007) Miroslaw Brys et al. NEUROBIOLOGY OF AGING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now